ONCOGENEX PHARMACEUTICALS IN

CUSIP: 68230A106 Class: COM

PRELUDE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001387508)

Note: Option positions (PUT/CALL) are excluded.

Q2 2017
Shares 6,600 Value ($000) $2 Avg Close Range
Q1 2017
Shares 21,100 Value ($000) $9 Avg Close Range
Q4 2016
Shares 8,600 Value ($000) $4 Avg Close Range
Q3 2016
Shares 6,600 Value ($000) $3 Avg Close Range
Q2 2016
Shares 4,600 Value ($000) $5 Avg Close Range
Q4 2014
Shares 4,633 Value ($000) $11 Avg Close Range
Q3 2014
Shares 4,633 Value ($000) $12 Avg Close Range
Q2 2014
Shares 4,633 Value ($000) $17 Avg Close Range
Q1 2014
Shares 3,300 Value ($000) $39 Avg Close Range
Q4 2013
Shares 1,992 Value ($000) $17 Avg Close Range
Q3 2013
Shares 1,992 Value ($000) $18 Avg Close Range
Q2 2013
Shares 5,000 Value ($000) $49 Avg Close Range